NCT00002257View on ClinicalTrials.gov

A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (13)

10016

New York Univ Med Ctr, New York

10021

Cornell Univ Med College, New York

19107

Buckley Braffman Stern Med Associates, Philadelphia

20007

Georgetown Univ Med Ctr, Washington D.C.

33125

Med Service, Miami

Miami Veterans Administration Med Ctr, Miami

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

77550

Univ TX Galveston Med Branch, Galveston

94114

Davies Med Ctr / c/o HIV Institute, San Francisco

94118

Dr David Busch, San Francisco

94704

East Bay AIDS Ctr, Berkeley

02215

Beth Israel Deaconess Med Ctr, Boston

Unknown

Saint Paul's Hosp, Vancouver

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002257 - A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS | Biotech Hunter | Biotech Hunter